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The current pharmaceutical business environment requires increasing agility, flexibility, and efficiency in 
bioprocess manufacturing to ensure competitiveness.  Excellence in technology transfer execution is one way to 
become more agile and to develop a competitive advantage.   Roche’s large manufacturing network, using both 
internal and external (CMO) manufacturing capabilities, provides many examples of various bioprocess 
technology transfers.   A consistent framework for technology transfer is used that incorporates elements of 
quality, speed, and risk management.  The amount of complexity is dictated by the level of changes in process, 
scale, or analytical methods as well as by the experience level of donor and receiving parties.  When external 
manufacturing (CMO) is included, additional complexities can arise due to differences in transfer methodologies, 
cultural norms, and communication styles.  Despite the complexities, a unified framework for transfers has 
allowed for significant reductions in transfer time.  A series of recent transfers for Roche commercial legacy 
processes will be described.  Facility fit considerations for upstream unit operations, scale-up/scale-down 
approaches, and obstacles encountered during manufacturing campaigns illustrate challenges encountered and 
overcome.  Specific examples to be discussed include approaches to address comparability challenges, cell 
culture scale-down model troubleshooting, and design modifications to media preparation equipment including 
high temperature short time (HTST) and bioburden control topics.      
 
 
